SEC Form 4 · accession 0001209191-15-024755
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Greg Madison
Officer — President and COO · Director
Period of report
Mar 6, 2015
Accepted (ET)
Mar 10, 2015 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 6, 2015 | P | 6,380 | $12.53 | D | 110,043 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 73,875 shares of restricted stock.